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Following the emergence of West Nile (WN) virus in New
York in 1999, state and local health departments in the
eastern United States, in conjunction with the Centers for
Disease Control and Prevention (CDC), established surveil-
lance systems for detecting WN virus activity (1). New York
City and New Jersey established active and enhanced passive
surveillance systems for human disease that encouraged
physician, infection control practitioner, and laboratory
reporting of suspected cases and provided testing for WN
virus. This report details the clinical characteristics of 19
hospitalized human cases that occurred during the summer
and fall of 2000; all patients resided in either New York City
(NYC) or New Jersey.
Methods
Enhanced surveillance for WN virus human disease in
New York and New Jersey during 2000 was instituted to
facilitate timely reporting of viral meningoencephalitis and to
ensure rapid and accurate laboratory testing for WN virus. In
NYC, encephalitis and viral meningitis are reportable
conditions. From May to October 2000, the following
measures were implemented by the NYC Department of
Health to supplement existing passive surveillance: 1)
Enhanced passive surveillance—To encourage physician
reporting citywide, information on WN virus reporting and
testing procedures was widely disseminated to the medical
community through invited presentations by departmental
medical staff, an agency publication mailed to >65,000
health-care providers, and biweekly broadcast facsimile and
e-mail alerts to all NYC hospitals; 2) Hospital-based active
physician surveillance—Neurologists, infectious disease
consultants, intensive-care physicians, and chief medical
residents at 18 sentinel NYC hospitals were called every 2
weeks to ascertain potential cases meeting clinical criteria; 3)
Hospital-based active laboratory surveillance—Laboratories
at 12 sentinel NYC hospitals submitted all cerebrospinal fluid
(CSF) specimens suggestive of a viral cause for WN virus
testing at the NYC health department (CSF with negative
Gram stain and culture with either a CSF leukocyte count
>5/mm3 or protein >40 mg/dL). A special unit was established
within the Communicable Disease Program of the NYC
Department of Health to implement these additional
surveillance activities. This unit ensured that all suspected
cases were prioritized for next-business-day specimen
collection and transportation to the city’s Public Health
Laboratories for WN virus testing.
In New Jersey, bacterial meningitis and encephalitis are
reportable to the New Jersey Department of Health and
Senior Services (NJDHSS). Active, hospital-based surveil-
lance by infection control practitioners targeted patients
admitted with the diagnoses of aseptic meningitis or
encephalitis in 42 hospitals in six northern counties. Passive
surveillance was enhanced through the distribution of
reporting protocols, surveillance criteria, and WN virus
educational materials to the medical community. Medical
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providers were reminded to notify the NJDHSS of suspected
cases. NJDHSS conducted weekly follow-up with physicians
and infection control practitioners to review the status of
pending cases.
A patient was considered to have a confirmed WN case if
he or she was hospitalized with an illness associated with
neurologic manifestations consistent with meningitis or
encephalitis, and had laboratory confirmation of WN
infection. The four laboratory confirmation criteria used for
WN infection, established by CDC (1), are as follows: 1)
isolation of WN virus from, or demonstration of WN viral
antigen or genomic sequences in tissue, blood, CSF, or other
body fluid; 2) demonstration of immunoglobulin M (IgM)
antibody to WN virus in CSF by IgM-capture enzyme
immunoassay (EIA); 3) >4-fold serial change in plaque-
reduction neutralizing antibody titer (PRNT) to WN virus in
paired, appropriately timed serum or CSF samples; and 4)
demonstration of both WN virus-specific IgM (by EIA) and
IgG (screened by EIA and confirmed by PRNT) antibody in a
single serum specimen.
Patients were classified into three clinical categories:
meningitis, if they had fever plus headache, stiff neck, or
photophobia; encephalitis, if they had altered mental status
or other cortical signs; or meningoencephalitis, if they met
both criteria. The categories of encephalitis and meningoen-
cephalitis were combined as “any encephalitis” in some
analyses. All syndromes required abnormal CSF findings
consistent with a viral cause (CSF with negative Gram stain
and culture with either a CSF leukocyte count >5/mm3 or
protein >40 mg/dL).
IgM-capture EIA was performed at either the NYC
Public Health Laboratories or the New Jersey Public
Health and Environmental Laboratory; confirmation of
positive results by PRNT was performed by CDC or the NY
State Department of Health. Viral neutralization testing
followed CDC protocol (R. Lanciotti, pers. commun.). Real-
time Taqman polymerase chain reaction (PCR) was
performed at CDC. Medical chart reviews and patient
interviews were completed on all patients with positive tests
for WN virus by IgM-capture EIA.
Supplementary medical chart reviews by the physician
authors were completed in November-December 2000 after
confirmation of initial results. Information abstracted
included demographics, symptoms, chronology of illness,
admission diagnosis, clinical findings, coexisting illness,
laboratory findings, hospital course, diagnostic procedures,
complications, level of neurologic involvement, discharge
condition, and diagnoses. If a symptom was not specifically
mentioned or a physical finding was not noted in the medical
record, it was considered to be absent. Patient addresses were
geocoded and mapped to compare the geography of the 2000
and 1999 epidemics. Descriptive statistics and Fisher’s exact
p values were calculated with SPSS (SPSS Chicago, version
10.0) and Epi Info (CDC, Atlanta, version 6.04b). Mapping
was done in ArcView (ERSI, Redlands, CA, version 3.2).
Results
Demographics
Nineteen hospitalized WN virus patients were identified
in 2000, 14 (74%) from New York and 5 (26%) from New
Jersey. The 14 New York cases were from four of the five NYC
counties; 10 were from Richmond County (Staten Island), 2
from Kings County (Brooklyn), and one each from New York
County (Manhattan) and Queens County. The New Jersey
cases occurred in Hudson County (2 cases) and in Bergen,
Morris, and Passaic counties (1 case each). Eleven (58%) were
male and eight (42%) were female. The median age was 63
years (range 36-87). Eight patients (42%) were >65 years of
age, and six (32%) of these were >75 years of age.
Clinical Illness and Hospital Course
Nine patients were classified as having encephalitis,
eight with meningitis and two with meningoencephalitis. All
eight patients >65 years of age had either encephalitis or
meningoencephalitis, accounting for 73% of all cases with
encephalitis. The mean age of patients with encephalitis was
71 years (standard deviation [SD]=11.7), compared with 51
years (SD=14.5) for patients with meningitis alone. A history
of hypertension (as documented in the past medical history
section of the medical record) was present in 8 (73%) of 11
patients with either encephalitis or meningoencephalitis,
compared with 3 (38%) of 8 patients with meningitis alone.
The median and mean time periods from symptom onset
to hospitalization were 3 and 7.7 days, respectively (range 0-
48). One patient became symptomatic 3 days after being
hospitalized for an unrelated, noninfectious condition, and
another was hospitalized 48 days after the initial onset of
symptoms. Patients’ onset dates occurred within a 9-week
interval from July 19 to September 12, 2000 (Figure 1). The
median length of hospital stay was 7 days (range 1-72), and
patients >65 years of age had a longer median length of stay
than those <65 years (11 days vs. 6 days). Five patients were
admitted to intensive care units (ICU), and two required
mechanical ventilation. The median length of stay in the ICU
was 17 days (range 2-47 days).
The patient’s temperature on admission ranged from
36.6°C to 40.6°C (median 38.6°C), and 14 patients were
febrile upon arrival at the emergency department (fever
defined as temperature of >38.0°C). Three patients became
febrile during their hospital stay, and two did not have
documented fever and were determined to have WN infection
based on a clinical diagnosis of meningitis or encephalitis and
laboratory confirmation. The mean duration of fever was 2.9
Figure 1. New York City metropolitan area West Nile virus epidemic
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days (range 0-6 days). The two patients without fever were
<41 years old. One denied a history of fever, while the other was
admitted 7 weeks after onset with an unclear history of fever.
The frequency of symptoms and clinical findings is
presented in Table 1. Neurologic and gastrointestinal
findings predominated. Of the 19 cases, 16 (84%) presented
with at least one neurologic complaint (headache, stiff neck,
photophobia, muscle weakness, or change in mental status).
Seventeen patients (89%) had one or more abnormalities on
neurologic examination. Motor exams in three patients
demonstrated muscle weakness (strength <5/5); of the six
with abnormal reflexes, four were hyporeflexive, and two had
abnormal plantar responses; the two patients with cerebellar
abnormalities were ataxic. Both patients with cranial nerve
abnormalities died; one had nystagmus and the other had a
depressed gag reflex.
Eleven patients (58%) had at least one gastrointestinal
symptom or had abnormal abdominal findings. Three
patients had rash. In two of these, the rash was truncal and
either macular or papular; the rash in the third patient was
not described.
Seventeen patients initially received antibiotics, and
eight were treated with acyclovir for presumptive herpes
encephalitis. One patient was comatose and was treated with
oral ribavirin and alpha-interferon without improvement.
This patient died of complications 16 weeks after transfer to a
long-term care facility.
Laboratory and Radiology Findings
Eighteen cases were diagnosed based on positive CSF
IgM-capture EIA; 9 of these were confirmed by a fourfold rise
in PRNT antibodies. An appropriately timed acute- or
convalescent-phase serum sample could not be obtained for
the remaining patients. Thirteen patients also had real-time
Taqman PCR testing of CSF, and one was positive (obtained 8
days after illness onset). One other patient, a 43-year-old
man, did not have sufficient CSF for testing; his case was
confirmed by positive serum IgM-capture EIA and PRNT
results in a single serum specimen. Seventeen patients had
an initial CSF pleocytosis, and 15 of these had a differential
cell count performed. Nine patients had a predominance of
neutrophils (>50%) in the CSF (Table 2). The presence of
neutrophilic pleocytosis was not associated with the more
severe presentation of encephalitis (p=0.5).
Three patients had hemoglobin values >2 SD below the
gender-specific mean values (73-year-old man, a 73-year-old
woman, and an 87-year-old woman). A low platelet count
(<150,000/mm3) occurred in one patient with a previous
history of thrombocytopenia, and another patient had a low
total leukocyte count (4,400/mm3). Abnormal serum sodium
levels (Na <135 mmol/L) occurred in eight (42%) patients.
This finding was noted more frequently in those with
encephalitis (hyponatremia in 6/11 with any encephalitis vs.
2/8 with meningitis). In two patients with hyponatremia and
encephalitis, the low serum sodium could be explained by
Table 1. Frequency of clinical findings in West Nile virus patients, New
York and New Jersey, 1999 and 2000
Frequency
Symptom or physical finding    No. (%)
Fever 17 (90)
Fatigue 12 (63)
Altered mental status 11 (58)
Headache 11 (58)
Reported weakness   8 (42)
Nausea   8 (42)
Vomiting   8 (42)
Myalgia   6 (32)
Photophobia   6 (32)
Abnormal reflexes   6 (32)
Stiff neck   6 (32)
Abdominal pain   4 (21)
Motor weakness   3 (16)
Cough   3 (16)
Diarrhea   3 (16)
Seizures   3 (16)
Arthralgia   2 (11)
Cerebellar abnormality   2 (11)
Cranial nerve palsy   2 (11)
Shortness of breath   2 (11)
Table 2. West Nile patient laboratory findings, New York and New Jersey, 1999 and 2000
Number      Mean value or N
Test tested (%)   with condition (range)  Normal values (2)
CSF
Leukocyte count, mean 19 (100)     308 mm3 (0-1782)       0-5 cells/mm3
Red cell count, mean 16 (84)     115/mm3 (0-700)       0 cells/mm3
Protein, mean 19 (100)     111 mg/dL (56-555)     15-50 mg/dL
Glucose, mean 19 (100)       67 mg/dL (48-95)     50-80 mg/dL
Differential,a >50% neutrophils 15 (79)         9 (1-100%) All mononuclear cells
Complete blood cell count
Leukocyte count, mean 19 (100) 10,600/mm3 (4,400-19,700) 4,500-11,000/mm3
Differential cell count,a >77% segs + bands 18 (95)       11 (55-96%)      59% ± 18
Hemoglobin (male), mean 11 (100)       14.5 g/dL (11.8-16.5)      15.5 g/dL ± 1.1
Hemoglobin (female), mean   8 (100)       12.7 g/dL (10.5-14.6)      13.7 g/dL ± 1.0
Other laboratory
Hyponatremia, serum Na <135 mmol/L 19 (100)         8 (42%)     135-145 mmol/L
Elevated AST, >twice upper limit 17 (90)         4 (24%)       10-35 units/L
Elevated ALT, >twice upper limit 15 (79)         1 (7%)       20-48 units/L
Elevated total bilirubin, >twice upper limit 16 (84)         3 (19%)         0.3-1.0 mg/dL
aValues are the number of patients with the laboratory finding;  ranges are the values of all patients.
CSF = cerebrospinal fluid; AST = aspartate aminotransferase; ALT = alanine aminotransferase; segs = segmented neutrophils.657 Vol. 7, No. 4, July–August 2001 Emerging Infectious Diseases
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other causes. One had spurious hyponatremia caused by
hyperglycemia (glucose=598 mg/dL), and the other had
elevated blood urea nitrogen (34 mg/dL) and urine specific
gravity (1.025) consistent with dehydration.
Radiographic imaging of the brain was conducted in 18
patients (95%). Eleven had computerized tomography, two
had magnetic resonance imaging, and five had both.
Abnormalities were noted in 10 (56%) patients. Eight had
nonacute abnormalities with either evidence of an old infarct,
mild communicating hydrocephalus, atrophy, leukomalacia,
or ischemia. Two had acute inflammatory changes: one had
leptomeningeal enhancement and the other had periventricu-
lar hyperintensity of the white matter. Seven of the eight
patients with evidence of old brain injury had encephalitis,
compared with two of eight with normal brain imaging
studies. A patient with Parkinson’s disease, diabetes, and
hypertension was the only patient in the series to have an
electromyogram. Results showed moderate-to-severe periph-
eral neuropathy, mainly demyelinating, with involvement of
sensory and motor neurons consistent with Guillain-Barré
syndrome.
Outcome
As recorded in discharge summaries, 10 patients (53%)
recovered but not to their functional level before illness, 7
(37%) recovered fully, and 2 died (11%). Both deaths occurred
in patients >80 years of age, and neither had an autopsy.
Thirteen (68%) patients were discharged to home, 4 (21%)
were discharged to a long-term care facility, one (5%) died in
the hospital, and the location of discharge of one patient (5%)
was unknown. When discharged from the acute-care facility,
seven (37%) were fully ambulatory, five (26%) were
ambulatory with assistance, two (11%) were bedridden, and
the condition was unknown for four (21%) patients. Five (26%)
patients required in-hospital physical therapy or consulta-
tion, three (16%) required speech therapy or consultation, and
two (11%) had occupational therapy or consultation.
Temporal and Geographic Trends
WN virus patients had onset dates in the 9-week period
from July 19 to September 12, 2000. The temporal
distribution of cases was bimodal, with four cases occurring
during the weeks of August 6-12 and August 27-September 2
(Figure 1). The epicenter was in Staten Island with the
hospitalized human cases encompassing an area of 1,520
square miles (Figure 2). During the first 6 weeks of the
epidemic, nine cases occurred on Staten Island, one in
Brooklyn, and two in New Jersey. In the final 3 weeks of the
epidemic, one case occurred on Staten Island, three cases
occurred in other New York City boroughs (one each in
Brooklyn, Manhattan, and Queens), and three cases occurred
in New Jersey.
Discussion
Nineteen hospitalized adults were diagnosed with WN
virus infection in the New York metropolitan area in 2000, a
decline of 68% from 1999. The epicenter was located in Staten
Island, approximately 20 miles west and south of the 1999
epicenter in northern Queens. Most patients had a febrile
illness associated with meningeal signs, altered mental
status, or both. The median age of hospitalized patients was
lower in 2000 (63 vs. 71 years), and the proportion with
encephalitis decreased from 63% to 58% (p=0.1). Gastrointes-
tinal complaints were common, and severe motor weakness
was reported less frequently than in 1999 (16% in 2000 vs.
27% in 1999). In 1999, seven deaths were caused by WN virus;
in 2000 two were. The case-fatality rates for the 2 years do not
differ statistically (11.9% in 1999, 10.5% in 2000, p=0.6).
Routine laboratory findings were nonspecific. CSF
findings were consistent with a nonbacterial inflammatory
process. Mild hyponatremia was found in eight patients. The
syndrome of inappropriate secretion of antidiuretic hormone
has been described in viral meningitis, St. Louis encephalitis,
and WN virus (3-5). Two of eight patients with hyponatremia
had other reasons for this finding (one with suspected
dehydration and the other with hyperglycemia), and
information on the use of antihypertensive medications,
including diuretics, was not collected nor were urine
osmolalities measured. A possible association of WN infection
with this syndrome cannot be determined from this case
series and requires further investigation.
Reasons for the differences seen in the number of human
cases over the two epidemic years are speculative. Aggressive
mosquito and larval control activities, particularly on Staten
Island, may have reduced the infected mosquito population
enough to diminish WN virus transmission to humans.
Increased immunity in the resident avian population may
have also prevented the re-establishment of an enzootic
amplification cycle sufficient to cause significant human
disease in Queens, the epicenter of the 1999 outbreak.
Evidence from an avian serosurvey conducted after the 1999
epidemic supports this theory, since 51% of birds captured in
Queens and 2% of those in Staten Island tested positive for
WN virus (6).
WN virus infection in hospitalized cases in 2000 occurred
over a 9-week period from mid-July to mid-September. A
greater proportion of cases occurring outside Staten Island
were recognized toward the end of this interval, which may
relate to differences in vector ecology or control measures
Figure 2. Metropolitan New York area hospitalized West Nile virus
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used. The timing of the 2000 epidemic curve closely resembles
that of the recent outbreak in Romania (7) and preceded the
1999 New York epidemic curve by 2 weeks. The earlier onset
in 2000 may have resulted from enhanced surveillance efforts
that were not in place before the 1999 outbreak was
recognized. In the 1996 Romanian outbreak, the predilection
for WN virus to cause severe disease with increasing age and
the frequency of gastrointestinal complaints were similar to
findings in this series. Most encephalitis cases were in
persons >50 years of age; vomiting occurred in 63% and
diarrhea in 12% of cases (8). The propensity of WN virus to
affect the elderly more seriously has been seen with other
flaviviruses, most notably St. Louis encephalitis (9). The
common contributing factors of age, hypertension, and
previous brain insult may relate to a decline in the integrity of
the blood brain barrier and facilitated access of WN virus to
the central nervous system.
The interpretation of the findings of this case series is
limited because of the small number of cases. Only
hospitalized patients were included, and most WN virus
infections are subclinical. Two additional nonhospitalized
WN fever cases, one in Connecticut and one in New Jersey,
were detected through surveillance and were not included in
this case series (10). Focusing on the most severely ill
obscures the true spectrum of WN illness. A 1999 serosurvey
in Queens, New York, estimates that for every hospitalized
case of WN virus infection there were 24 mild febrile and 110
subclinical illnesses (F. Mostashari, pers. commun.).
Surveillance in 2000 focused on adults with aseptic
meningitis or encephalitis; patients <18 years old were only
included if they had encephalitis. The active laboratory
surveillance component, however, included patients <18
years old. Four hundred fifty-three CSF specimens were
received through active laboratory surveillance; 13 (3%) were
from children <18 years. No positive results in children were
found.
Another limitation was that the data described were
abstracted from medical records that varied greatly in their
completeness and legibility. The frequency of missing,
missed, and omitted information was approximately 5%-10%.
For some analyses, clinical information not located in the
medical record was coded as negative, possibly introducing
bias that could have produced spurious or hidden real
associations.
WN virus appears to have established an enzootic cycle in
the northeast United States with positive avian or mosquito
findings extending from New Hampshire to North Carolina
(11). Clinicians practicing along the eastern seaboard should
consider this diagnosis when evaluating febrile patients
during the summer months with neurologic complaints,
especially those with a gastrointestinal prodrome or muscle
weakness.
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